Protein delivery options: how well have we succeeded?
Of the ten top-selling drugs in 2013, the first three (Humira®, Enbrel®, Remicade®) were all monoclonal antibodies for treating autoimmune diseases; together these three accounted for approximately $28 billion in sales. Another antibody, Avastin®, indicated for bowel cancer, accounted for $6.7 billi...
Saved in:
Main Authors: | Ng, Xu Wen, Subbu, Venkatraman |
---|---|
Other Authors: | School of Materials Science & Engineering |
Format: | Article |
Language: | English |
Published: |
2017
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/83239 http://hdl.handle.net/10220/42495 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Molecular cloning of antigen encoding genes from Opisthorchis Viverrini (liver fluke) and primary analysis of encoded proteins
by: Veerachai Eursitthichai, 1976-
Published: (2023) -
Identification of HUGT1 as a potential BiP activator and a cellular target for improvement of recombinant protein production using a cDNA screening system
by: Ku, S.C.Y., et al.
Published: (2014) -
THERMOSTABLE EXOSHELLS AS TOOLS FOR RECOMBINANT PROTEIN EXPRESSION AND IN VIVO DELIVERY
by: MASURKAR NIHAR
Published: (2018) -
Neutralizing chimeric mouse-human antibodies against Burkholderia pseudomallei protease: Expression, purification and characterization
by: Chan, S.-W., et al.
Published: (2016) -
SYNTHETIC PROTEIN DESIGN AND ENGINEERING OF A MONOCLONAL ANTIBODY
by: MAXIMILIAN KLEMENT
Published: (2015)